Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.
This study has been completed.
Study NCT00677105   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on May 8, 2008.   Last Updated on September 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
JNJ-26481585
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Janssen Pharmaceutica N.V., Belgium


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services